S 344
116th Congress
Senate
Health
Administrative remedies
Drug safety, medical device, and laboratory regulation
Fraud offenses and financial crimes
Intellectual property
Licensing and registrations
Prescription drugs
Securities
Hatch-Waxman Integrity Act of 2019
Introduced: February 6, 2019
Introduced by:
Tillis, Thomas
Republican
· North Carolina
See on congress.gov
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 6, 2019
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Feb 6, 2019
Introduced in Senate
Plain-English summary
Hatch-Waxman Integrity Act of 2019
This bill establishes certain limits on the filing of patent validity challenges with the Patent Trial and Appeal Board, particularly with respect to inter partes review.
What's happening now
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Committees of jurisdiction
1